Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
Latest action · Jun 26, 2019 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 14, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
This bill addresses prescription drugs and extends several health care, research, and workforce programs.
Currently, a generic drug manufacturer is awarded 180 days of exclusivity on the market if it is the first applicant to file an application with the Food and Drug Administration (FDA), and the exclusivity period begins upon the first applicant's commercial marketing. The bill authorizes the FDA to approve a subsequent generic drug application prior to the first applicant's first date of commercial marketing if certain conditions are met.
The bill prohibits a brand-name, generic, or biosimilar drug manufacturer from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement, with specified exclusions, is a violation of the bill if the filer of the subsequent generic application receives something of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biological product.
The developer of a drug or biological product, such as a generic or biosimilar version of a drug, may bring a civil action against the license holder of an approved drug if the holder has declined to make available sufficient quantities of the approved drug for the developer's testing.
The bill also extends several health care, research, and workforce programs, including the National Health Service Corps, through FY2020.
Cosponsors 44
Members who signed on, in the order they did. Signatures ran from May 14, 2019 to Dec 5, 2019; 29 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IL | Adam Kinzinger | Original | May 14, 2019 |
| R-TX | Bill Flores | Original | May 14, 2019 |
| R-OH | Bill Johnson | Original | May 14, 2019 |
| R-MO | Billy Long | Original | May 14, 2019 |
| R-KY | Brett Guthrie | Original | May 14, 2019 |
| R-WA | Cathy McMorris Rodgers | Original | May 14, 2019 |
| R-WV | David B. McKinley | Original | May 14, 2019 |
| R-GA | Doug Collins | Original | May 14, 2019 |
| R-GA | Earl L. "Buddy" Carter | Original | May 14, 2019 |
| R-WI | F. James Sensenbrenner, Jr. | Original | May 14, 2019 |
| R-MI | Fred Upton | Original | May 14, 2019 |
| R-MT | Greg Gianforte | Original | May 14, 2019 |
| R-OR | Greg Walden | Original | May 14, 2019 |
| R-FL | Gus M. Bilirakis | Original | May 14, 2019 |
| R-VA | H. Morgan Griffith | Original | May 14, 2019 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 14, 2019 |
| Health Subcommittee | Referred May 15, 2019 | |
| House | Judiciary Committee | Referred May 14, 2019 |
| Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee | Referred Jun 26, 2019 | |
| Administrative State, Regulatory Reform, and Antitrust Subcommittee | Referred Jun 26, 2019 |
Actions 5
Everything that happened, newest first.
- Jun 26, 2019Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
- Jun 26, 2019Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
- May 15, 2019Referred to the Subcommittee on Health.
- May 14, 2019Introduced in House
- May 14, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H4013 | Mike Bost R-IL | May 21, 2019 |
| House | Debate and remarks H3856, H3857 | Michael C. Burgess R-TX | May 16, 2019 |
| House | Debate and remarks H3804 | Michael C. Burgess R-TX | May 15, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 80, May 14, 2019, page H3790.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-40 | INVESTING IN AMERICA'S HEALTHCARE294 pages | Energy and Commerce Committee | Jun 4, 2019 |
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
| IN11063 | Special Diabetes Programs Expire in FY2020: Policy Considerations and Extension Proposals Archived | Insight | Jan 16, 2020 |
Related bills 11
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 19 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
| S 192 | Community and Public Health Programs Extension Act | Related bill | Jan 18, 2019 |
| S 340 | CREATES Act of 2019 | Related bill | Feb 6, 2019 |
| HR 938 | BLOCKING Act of 2019 | Related bill | May 2, 2019 |
| HR 965 | CREATES Act of 2019 | Related bill | May 16, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To incentivize low-cost drug options and generic competition, and to provide extensions for community health centers and the National Health Service Corps, and for other purposes.
- Short Title(s) as Introduced
- Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Appropriations
- Child health
- Civil actions and liability
- Competition and antitrust
- Consumer affairs
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Education programs funding
- Family planning and birth control
- Federal Trade Commission (FTC)
- Health
- Health care costs and insurance
- Health care coverage and access
- Health facilities and institutions
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Indian social and development programs
- Inflation and prices
- Judicial review and appeals
- Licensing and registrations
- Marketing and advertising
- Medical education
- Medical research
- Minority health
- National and community service
- Prescription drugs
- Product development and innovation
- Sex and reproductive health
- Social work, volunteer service, charitable organizations
Text 1
Each version as it was printed, newest first.
- May 14, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.